Ischemia-induced copper loss and suppression of angiogenesis in the pathogenesis of myocardial infarction

Cardiovascular Toxicology

Volumn 13, Issue 1, 2013, Pages 1-8

  He, Weihong ^a   James Kang, Y ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

Copper; Heart; HIF 1; Ischemia; Toxicity

Indexed keywords

COPPER; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY DENSITY; COMPLEX FORMATION; DISEASE MODEL; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; COPPER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84872617524     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-012-9174-y     Document Type: Article

References (86)

1. Goswami, S. K.; & Das, D. K. (2010). Oxygen sensing, cardiac ischemia, HIF-1alpha and some emerging concepts. Current Cardiology Reviews, 6, 265-273.
2. Tekin, D.; Dursun, A. D.; & Xi, L. (2010). Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacologica Sinica, 31, 1085-1094.
3. Eckle, T.; Kohler, D.; Lehmann, R.; El Kasmi, K.; & Eltzschig, H. K. (2008). Hypoxia-inducible factor-1 is central to cardioprotection: A new paradigm for ischemic preconditioning. Circulation, 118, 166-175.
4. Bautista, L.; Castro, M. J.; López-Barneo, J.; & Castellano, A. (2009). Hypoxia inducible factor-2alpha stabilization and maxi-K+ channel beta1-subunit gene repression by hypoxia in cardiac myocytes: Role in preconditioning. Circulation Research, 104, 1364-1372.
5. Arab, A.; Kuemmerer, K.; Wang, J.; Bode, C.; & Hehrlein, C. (2008). Oxygenated perfluorochemicals improve cell survival during reoxygenation by pacifying mitochondrial activity. Journal of Pharmacology and Experimental Therapeutics, 325, 417-424. (Pubitemid 351574786)
6. Jürgensen, J. S.; Rosenberger, C.; Wiesener, M. S.; Warnecke, C.; Hörstrup, J. H.; Gräfe, M.; et al. (2004). Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. The FASEB Journal, 18, 1415-1417. (Pubitemid 39561599)
7. Meeson, A. P.; Radford, N.; Shelton, J. M.; Mammen, P. P.; DiMaio, J. M.; Hutcheson, K.; et al. (2001). Adaptive mechanisms that preserve cardiac function in mice without myoglobin. Circulation Research, 88, 713-720. (Pubitemid 32378141)
8. Shohet, R. V.; & Garcia, J. A. (2007). Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia. Journal of Molecular Medicine (Berlin, Germany), 85, 1309-1315. (Pubitemid 50004092)
9. Kim, J. W.; Tchernyshyov, I.; Semenza, G. L.; & Dang, C. V. (2006). HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metabolism, 3, 177-185.
10. Rey, S.; & Semenza, G. L. (2010). Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovascular Research, 86, 236-242.
11. Hinkel, R.; Trenkwalder, T.; & Kupatt, C. (2011). Gene therapy for ischemic heart disease. Expert Opinion on Biological Therapy, 11, 723-737.
12. Tyagi, S. C. (1997). Vasculogenesis and angiogenesis: Extracellular matrix remodeling in coronary collateral arteries and the ischemic heart. Journal of Cellular Biochemistry, 65, 388-394. (Pubitemid 27190693)
13. Metivier, F.; Marchais, S. J.; Guerin, A. P.; Pannier, B.; & London, G. M. (2000). Pathophysiology of anaemia: Focus on the heart and blood vessels. Nephrology, Dialysis, Transplantation, 15(Suppl 3), 14-18.
14. Frangogiannis, N. G.; & Entman, M. L. (2005). Chemokines in myocardial ischemia. Trends in Cardiovascular Medicine, 15, 163-169. (Pubitemid 41297626)
15. Chevion, M.; Jiang, Y.; Har-El, R.; Berenshtein, E.; Uretzky, G.; & Kitrossky, N. (1993). Copper and iron are mobilized following myocardial ischemia: Possible predictive criteria for tissue injury. Proceedings of the National Academy of Sciences of the United States of America, 90, 1102-1106. (Pubitemid 23053959)
16. Tapiero, H.; Townsend, D. M.; & Tew, K. D. (2003). Trace elements in human physiology and pathology. Copper. Biomedicine & Pharmacotherapy, 57, 386-398. (Pubitemid 37494714)
17. Davis, G. K.; & Mertz, W. (1987). Trace elements in human and animal nutrition (pp. 301-364). New York: Academic Press.
18. Dutt, B.; & Mills, C. F. (1960). Reproductive failure in rats due to copper deficiency. Journal of Comparative Pathology, 70, 120-125.
19. Fell, B. F.; Farquharson, C.; & Riddoch, G. I. (1987). Kidney lesions in copper-deficient rats. Journal of Comparative Pathology, 97, 187-196. (Pubitemid 17061832)
20. Goodman, J. R.; Warshaw, J. B.; & Dallman, P. R. (1970). Cardiac hypertrophy in rats with iron and copper deficiency: Quantitative contribution of mitochondrial enlargement. Pediatric Research, 4, 244-256.
21. Kopp, S. J.; Klevay, L. M.; & Feliksik, J. M. (1983). Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency. The American Journal of Physiology, 245, H855-H866.
22. Elsherif, L.; Ortines, R. V.; Saari, J. T.; & Kang, Y. J. (2003). Congestive heart failure in copper-deficient mice. Experimental Biology and Medicine (Maywood, NJ), 228, 811-817. (Pubitemid 37169266)
23. Wildman, R. E.; Hopkins, R.; Failla, M. L.; & Medeiros, D. M. (1995). Marginal copper-restricted diets produce altered cardiac ultrastructure in the rat. Proceedings of the Society for Experimental Biology and Medicine, 210, 43-49.
24. Li, Y.; Wang, L.; Schuschke, D. A.; Zhou, Z.; Saari, J. T.; & Kang, Y. J. (2005). Marginal dietary copper restriction induces cardiomyopathy in rats. The Journal of Nutrition, 135, 2130-2136. (Pubitemid 41298377)
25. Wester, P. O. (1965). Trace elements in human myocardial infarction determined by neutron activation analysis. Acta Medica Scandinavica, 178, 765-788.
26. Zama, N.; & Towns, R. (1986). Cardiac copper, magnesium, and zinc in recent and old myocardial infarction. Biological Trace Element Research, 10, 201-208.
27. Chipperfield, B.; & Chipperfield, J. R. (1978). Differences in metal content of the heart muscle in death from ischemic heart disease. American Heart Journal, 95, 732-737. (Pubitemid 9006512)
28. Prohaska, J. R. (1990). Biochemical changes in copper deficiency. The American Journal of Clinical Nutrition, 1, 452-461. (Pubitemid 20328386)
29. Medeiros, D. M.; Davidson, J.; & Jenkins, J. E. (1993). A unified perspective on copper deficiency and cardiomyopathy. Proceedings of the Society for Experimental Biology and Medicine, 203, 262-273. (Pubitemid 23183057)
30. Feng, W.; Ye, F.; Xue, W.; Zhou, Z.; & Kang, Y. J. (2009). Copper regulation of hypoxia-inducible factor-1 activity. Molecular Pharmacology, 75, 174-182.
31. Wang, G. L.; Jiang, B. H.; Rue, E. A.; & Semenza, G. L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92, 5510-5514.
32. Huang, L. E.; Gu, J.; Schau, M.; & Bunn, H. F. (1998). Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America, 95, 7987-7992.
33. Wang, G. L.; & Semenza, G. L. (1993). General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 90, 4304-4308. (Pubitemid 23134215)
34. Jaakkola, P.; Mole, D. R.; Tian, Y. M.; Wilson, M. I.; Gielbert, J.; Gaskell, S. J.; et al. (2001). Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science, 292, 468-472. (Pubitemid 32335942)
35. Ivan, M.; Kondo, K.; Yang, H.; Kim, W.; Valiando, J.; Ohh, M.; et al. (2001). HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing. Science, 292, 464-468. (Pubitemid 32335941)
36. Maxwell, P. H.; Wiesener, M. S.; Chang, G. W.; Clifford, S. C.; Vaux, E. C.; Cockman, M. E.; et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275. (Pubitemid 29246458)
37. Masson, N.; Willam, C.; Maxwell, P. H.; Pugh, C. W.; & Ratcliffe, P. J. (2001). Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. The EMBO Journal, 20, 5197-5206. (Pubitemid 32910914)
38. Ohh, M.; Park, C. W.; Ivan, M.; Hoffman, M. A.; Kim, T. Y.; Huang, L. E.; et al. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nature Cell Biology, 2, 423-427.
39. Tanimoto, K.; Makino, Y.; Pereira, T.; & Poellinger, L. (2000). Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. The EMBO Journal, 19, 4298-4309. (Pubitemid 30623741)
40. Hirsila, M.; Koivunen, P.; Xu, L.; Seeley, T.; Kivirikko, K. I.; & Myllyharju, J. (2005). Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB Journal, 19, 1308-1310. (Pubitemid 41113732)
41. Ke, Q.; Kluz, T.; & Costa, M. (2005). Down-regulation of the expression of the FIH-1 and ARD-1 genes at the transcriptional level by nickel and cobalt in the human lung adenocarcinoma A549 cell line. International Journal of Environmental Research and Public Health, 2, 10-13. (Pubitemid 40965096)
42. Maxwell, P.; & Salnikow, K. (2004). HIF-1: an oxygen and metal responsive transcription factor. Cancer Biology & Therapy, 3, 29-35. (Pubitemid 41342413)
43. Yuan, Y.; Hilliard, G.; Ferguson, T.; & Millhorn, D. E. (2003). Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha. The Journal of Biological Chemistry, 278, 15911-15916. (Pubitemid 36799707)
44. Mahon, P. C.; Hirota, K.; & Semenza, G. L. (2001). FIH-1: A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes & Development, 15, 2675-2686. (Pubitemid 32988878)
45. Lando, D.; Peet, D. J.; Gorman, J. J.; Whelan, D. A.; Whitelaw, M. L.; & Bruick, R. K. (2002). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes & Development, 16, 1466-1471. (Pubitemid 34686328)
46. Lando, D.; Peet, D. J.; Whelan, D. A.; Gorman, J. J.; & Whitelaw, M. L. (2002). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science, 295, 858-861. (Pubitemid 34118367)
47. McNeill, L. A.; Hewitson, K. S.; Claridge, T. D.; Seibel, J. F.; Horsfall, L. E.; & Schofield, C. J. (2002). Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. The Biochemical Journal, 367, 571-575. (Pubitemid 35305697)
48. Freedman, S. J.; Sun, Z. Y.; Poy, F.; Kung, A. L.; Livingston, D. M.; Wagner, G.; et al. (2002). Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proceedings of the National Academy of Sciences of the United States of America, 99, 5367-5372. (Pubitemid 34411554)
49. Dames, S. A.; Martinez-Yamout, M.; De Guzman, R. N.; Dyson, H. J.; & Wright, P. E. (2002). Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proceedings of the National Academy of Sciences of the United States of America, 99, 5271-5276. (Pubitemid 34411538)
50. Wang, G. L.; & Semenza, G. L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction. Blood, 82, 3610-3615. (Pubitemid 24006041)
51. Jiang, B. H.; Jiang, G.; Zheng, J. Z.; Lu, Z.; Hunter, T.; & Vogt, P. K. (2001). Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth & Differentiation, 12, 363-369. (Pubitemid 32685637)
52. Sandau, K. B.; Faus, H. G.; & Brüne, B. (2000). Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3 K pathway. Biochemical and Biophysical Research Communications, 278, 263-267.
53. Treins, C.; Giorgetti-Peraldi, S.; Murdaca, J.; Semenza, G. L.; & Van Obberghen, E. (2002). Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. The Journal of Biological Chemistry, 277, 27975-27981. (Pubitemid 34966746)
54. Tramontano, A. F.; Muniyappa, R.; Black, A. D.; Blendea, M. C.; Cohen, I.; Deng, L.; et al. (2003). Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway. Biochem Biochemical and Biophysical Research Communications, 308, 990-994. (Pubitemid 36976556)
55. Kim, C. H.; Cho, Y. S.; Chun, Y. S.; Park, J. W.; & Kim, M. S. (2002). Early expression of myocardial HIF-1alpha in response to mechanical stresses: Regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circulation Research, 90, E25-E33.
56. Lee, S. H.; Wolf, P. L.; Escudero, R.; Deutsch, R.; Jamieson, S. W.; & Thistlethwaite, P. A. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. The New England Journal of Medicine, 342, 626-633. (Pubitemid 30118415)
57. Jurgensen, J. S.; Rosenberger, C.; Wiesener, M. S.; Warnecke, C.; Horstrup, J. H.; Grafe, M.; et al. (2004). Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. FASEB Journal, 18, 1415-1417. (Pubitemid 39561599)
58. Kido, M.; Du, L.; Sullivan, C. C.; Li, X.; Deutsch, R.; Jamieson, S. W.; et al. (2005). Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. Journal of the American College of Cardiology, 46, 2116-2124. (Pubitemid 41713601)
59. Date, T.; Mochizuki, S.; Belanger, A. J.; Yamakawa, M.; Luo, Z.; Vincent, K. A.; et al. (2005). Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. American Journal of Physiology. Cell Physiology, 288, C314-C320.
60. Kaelin, W. G.; Jr, & Ratcliffe, P. J. (2008). Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell, 30, 393-402. (Pubitemid 351681994)
61. Berra, E.; Benizri, E.; Ginouves, A.; Volmat, V.; Roux, D.; & Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. The EMBO Journal, 22, 4082-4090. (Pubitemid 37021737)
62. Minamishima, Y. A.; Moslehi, J.; Bardeesy, N.; Cullen, D.; Bronson, R. T.; & Kaelin, W. G.; Jr. (2008). Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood, 111, 3236-3244.
63. Appelhoff, R. J.; Tian, Y. M.; Raval, R. R.; Turley, H.; Harris, A. L.; Pugh, C. W.; et al. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. The Journal of Biological Chemistry, 279, 38458-38465. (Pubitemid 39295997)
64. Minamishima, Y. A.; Moslehi, J.; Padera, R. F.; Bronson, R. T.; Liao, R.; & Kaelin, W. G.; Jr. (2009). A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Molecular and Cellular Biology, 29, 5729-5741.
65. Huang, M.; Chan, D. A.; Jia, F.; Xie, X.; Li, Z.; Hoyt, G.; et al. (2008). Short hairpin RNA interference therapy for ischemic heart disease. Circulation, 118, S226-S233.
66. Lei, L.; Mason, S.; Liu, D.; Huang, Y.; Marks, C.; Hickey, R.; et al. (2008). Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Molecular and Cellular Biology, 28, 3790-3803. (Pubitemid 351732913)
67. Moslehi, J.; Minamishima, Y. A.; Shi, J.; Neuberg, D.; Charytan, D. M.; Padera, R. F.; et al. (2010). Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation, 122, 1004-1016.
68. Bekeredjian, R.; Walton, C. B.; MacCannell, K. A.; Ecker, J.; Kruse, F.; Outten, J. T.; et al. (2010). Conditional HIF-1alpha expression produces a reversible cardiomyopathy. PLoS ONE, 5, e11693.
69. Giacca, M.; & Zacchigna, S. (2012). VEGF gene therapy: Therapeutic angiogenesis in the clinic and beyond. Gene Therapy,. doi: 10.1038.
70. Eibel, B.; Rodrigues, C. G.; Giusti, I. I.; Nesralla, I. A.; Prates, P. R.; Sant'Anna, R. T.; et al. (2011). Gene therapy for ischemic heart disease: Review of clinical trials. The Revista Brasileira de Cirurgia Cardiovascular, 26, 635-646.
71. Jeremy, J. Y.; Shukla, N.; Angelini, G. D.; Day, A.; Wan, I. Y.; Talpahewa, S. P.; et al. (2002). Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting. The Annals of Thoracic Surgery, 74, 1553-1557. (Pubitemid 35222640)
72. Mansoor, M. A.; Bergmark, C.; Haswell, S. J.; Savage, I. F.; Evans, P. H.; Berge, R. K.; et al. (2000). Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clinical Chemistry, 46, 385-391. (Pubitemid 30152265)
73. Shukla, N.; Angelini, G. D.; & Jeremy, J. Y. (2007). Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein. The Annals of Thoracic Surgery, 84, 43-49. (Pubitemid 46921154)
74. Apostolova, M. D.; Bontchev, P. R.; Ivanova, B. B.; Russell, W. R.; Mehandjiev, D. R.; Beattie, J. H.; et al. (2003). Copper-homocysteine complexes and potential physiological actions. Journal of Inorganic Biochemistry, 95, 321-333. (Pubitemid 36775349)
75. Carrasco-Pozo, C.; Alvarez-Lueje, A.; Olea-Azar, C.; Lopez-Alarcon, C.; & Speisky, H. (2006). In vitro interaction between homocysteine and copper ions: Potential redox implications. Experimental Biology and Medicine (Maywood, NJ), 231, 1569-1575. (Pubitemid 44547852)
76. Emsley, A. M.; Jeremy, J. Y.; Gomes, G. N.; Angelini, G. D.; & Plane, F. (1999). Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. British Journal of Pharmacology, 126, 1034-1040. (Pubitemid 29103721)
77. Linnebank, M.; Lutz, H.; Jarre, E.; Vielhaber, S.; Noelker, C.; Struys, E.; et al. (2006). Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells. Neurobiology of Disease, 23, 725-730. (Pubitemid 44234108)
78. Martin, F.; Linden, T.; Katschinski, D. M.; Oehme, F.; Flamme, I.; Mukhopadhyay, C. K.; et al. (2005). Copper-dependent activation of hypoxia-inducible factor (HIF)-1: Implications for ceruloplasmin regulation. Blood, 105, 4613-4619. (Pubitemid 40807279)
79. van Heerden, D.; Vosloo, A.; & Nikinmaa, M. (2004). Effects of short-term copper exposure on gill structure, metallothionein and hypoxia-inducible factor-1alpha (HIF-1alpha) levels in rainbow trout (Oncorhynchus mykiss). Aquatic Toxicology, 69, 271-280. (Pubitemid 38970052)
80. Jiang, Y.; Reynolds, C.; Xiao, C.; Feng, W.; Zhou, Z.; Rodriguez, W.; et al. (2007). Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice. The Journal of Experimental Medicine, 204, 657-666. (Pubitemid 46457087)
81. Ziche, M.; Jones, J.; & Gullino, P. M. (1982). Role of prostaglandin E1 and copper in angiogenesis. Journal of the National Cancer Institute, 69, 475-482.
82. Harris, E. D. (2004). A requirement for copper in angiogenesis. Nutrition Reviews, 62, 60-64. (Pubitemid 38327618)
83. Lowndes, S. A.; & Harris, A. L. (2005). The role of copper in tumour angiogenesis. Journal of Mammary Gland Biology and Neoplasia, 10, 299-310. (Pubitemid 44256410)
84. Nasulewicz, A.; Mazur, A.; & Opolski, A. (2004). Role of copper in tumour angiogenesis-clinical implications. Journal of Trace Elements in Medicine and Biology, 18, 1-8. (Pubitemid 39285958)
85. Goodman, V. L.; Brewer, G. J.; & Merajver, S. D. (2005). Control of copper status for cancer therapy. Current Cancer Drug Targets, 5, 543-549. (Pubitemid 41502565)
86. Sen, C. K.; Khanna, S.; Venojarvi, M.; Trikha, P.; Ellison, E. C.; Hunt, T. K.; et al. (2002). Copper-induced vascular endothelial growth factor expression and wound healing. American Journal of Physiology: Heart and Circulatory Physiology, 282, H1821-H1827.